THIERRY BORDET
Chief Scientific Officer
FranceResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Thierry Bordet is the Chief Scientific Officer at EYEVENSYS in France. His research focuses on neuroprotective effects in glaucoma, gene therapy for uveitis, and treatments for retinal degeneration. Recent publications include studies on the role of transferrin in experimental models and the efficacy of anti-TNF-α in non-infectious uveitis.
Articles (4)
Year:
2022
Year:
2021
Year:
2020
Year:
2020
Collaborators (1)
Denise Inman
Associate Professor
University of North Texas Health Science Center
UNITED STATES
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.